Clinical trials
Phase 1 Hypercholesterolemia trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 2 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Verve Therapeutics, Inc. | 2 |
| Alnylam Pharmaceuticals | 1 |
| CRISPR Therapeutics AG | 1 |
| Civi Biopharma, Inc. | 1 |
| Novo Nordisk A/S | 1 |
| Queen Mary University of London | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 10 |
| Dyslipidemias | 3 |
| Hyperlipoproteinemia Type II | 2 |
| Hypertriglyceridemia | 2 |
| Atherosclerosis | 1 |
| Cardiovascular Diseases | 1 |
| Homozygous Familial Hypercholesterolemia | 1 |
| Hyperlipidemias | 1 |
| Hyperlipoproteinemia Type V | 1 |
| Lipid Metabolism Disorders | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.